OmniAb, Inc. (OABI)
2.70
-0.02
(-0.74%)
USD |
NASDAQ |
May 29, 16:00
2.71
+0.01
(+0.37%)
Pre-Market: 20:00
OmniAb EPS Diluted (Quarterly) : -0.0601 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.614 |
| Inotiv, Inc. | -0.9369 |
| Champions Oncology, Inc. | -0.0201 |
| Medpace Holdings, Inc. | 4.277 |
| Charles River Laboratories International, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.707M |
| Revenue (Quarterly) | 14.43M |
| Total Expenses (Quarterly) | 22.13M |
| Enterprise Value | 362.02M |
| Gross Profit Margin (Quarterly) | 49.89% |
| Profit Margin (Quarterly) | -53.42% |
| Earnings Yield | -17.21% |
| Normalized Earnings Yield | -17.40 |